Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research collaboration with Janssen Biotech, Inc. (Janssen), one of the Pharmaceutical Companies of Johnson & Johnson. Under the terms of the agreement, Janssen will have the exclusive option to research, develop and commercialize novel biological therapeutic candidates based on…
Read More

Voicing the Silent Genomes: New Documentary Features GSC Scientist, Dr. Nadine Caron

The vision of precision medicine is customized health care—preventative measures, disease treatments, practices and products tailored to individuals. Genomics is leading the charge by investigating and cataloguing the chemistry of life using an ever-increasing range of nucleic acid sequencing techniques and powerful computational technologies. But what if the genomic information that is being databased and used to inform modern medical…
Read More
Research by scientists at the University of British Columbia (UBC) and the BC Cancer Research Institute (BCCRI) has uncovered a new combination treatment that may overcome drug resistance in pancreatic cancer, one of the most deadly cancers.The study, recently published in Cell Reports Medicine, identified a new combination treatment strategy that prevents a type of pancreatic tumour, known as pancreatic ductal…
Read More

The GSC Welcomes Dr. Laura Evgin

The GSC is pleased to announce the arrival of our newest faculty member, Dr. Laura Evgin. As of November 2, she is Scientist at the GSC and an Assistant Professor in the Department of Medical Genetics at the University of British Columbia. Dr. Evgin’s research is focused on Chimeric antigen receptor (CAR) modified T cells and oncolytic viruses. CAR T cells CAR…
Read More
COVID toes led an international group of researchers to identify a previously unknown role of Immunoglobulin A (IgA) in severe COVID-19. To date, over 50 million people have been affected by COVID-19 since the start of the pandemic. More than one million deaths have resulted from a range of virus-associated causes and complications, including acute respiratory distress syndrome and blood…
Read More
AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced the companies have expanded their agreement to generate therapeutic antibody candidates for serious and chronic conditions in animal health. Based on AbCellera’s successful delivery…
Read More
LSI researchers are challenging the conventional wisdom on methylation of sperm DNA following fertilization of eggs. For years, sperm DNA has been thought to be mostly stripped of methylation (5-methylcytosine) in the aftermath of conception. But recent findings published in Nature Communications have shown that in the first stages of life, some regions on incoming paternal chromosomes actually show a…
Read More
Since the legalization of cannabis in Canada last year, Cannabidiol (CBD), an active component of cannabis, continues to make health news. Reza Ghovanloo, a recent SFU PhD graduate  in biomedical physiology and kinesiology (BPK), says his research helps to understand why there are so many health claims related to CBD. Ghovanloo, together with his supervisor, SFU professor Peter Ruben and additional members…
Read More
Grizzly bears are an ecologically, culturally, and economically valuable species for British Columbia and Canada. Due to this importance, many populations are intensively monitored by First Nation and provincial governments to ensure effective and evidence-based management to safeguard a healthy population for the future. A key component of monitoring programs is the ability to identify individual bears using a set…
Read More

Peptide-Based Drugs: A SPOT More Stable

Host defense peptides – in addition to their synthetic analogues, innate defense regulator (IDR) peptides – have recently gained attention as a new strategy for treating challenging infections. These peptides can have a variety of therapeutic functions, such as increasing the recruitment of immune cells to the site of infection and modulating inflammation, as well as targeting biofilms, the bacterial communities…
Read More